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ABSTRACT
Cartilage derived stem/progenitor cells (CSPCs) have been isolated from a variety of cartilage sources and are suggested to have high chondrogenic
potential. However, their role in cartilage engineering has not been well described, in particular, compared to other more widely used cell types
such as differentiated chondrocytes and nontissue-speciﬁc mesenchymal stem cells (MSCs). The authors performed a systematic review of litera-
ture according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines [Web of Science (Web of Science Core
Collection, BIOSIS Citation Index, KCI-Korean Journal Database, MEDLINE, SciELO Citation Index), PubMed, and Embase] from January 1947
to November 2017, to evaluate CSPC isolation, their characterization, and cartilage regeneration. Two investigators independently reviewed all
studies and extracted the data against standardized inclusion/exclusion criteria. A total of 1189 studies were identiﬁed, 65 of which met the inclu-
sion criteria, consisting of 69 reports on CSPC isolation from articular (n¼ 35), intervertebral disk (11), auricular (n¼ 10), meniscal (n¼ 5), naso-
septal (n¼ 5), tracheal (n¼ 2), and costal (n¼ 1) cartilages. Despite the heterogeneity in isolation methods, 75% of studies found CSPCs to have
trilineage differentiation potential, with consistent but nonspeciﬁc cell surface marker expression proﬁles, being positive for the recognized MSC
markers CD90, CD105, CD44, CD166, CD73, and CD29 and negative for hematopoietic markers CD34 and CD45. Four cartilage regenerative
outcomes were assessed: chondrogenic gene and protein expression (quantitative polymerase chain reaction, histology, immunohistochemistry,
and biochemistry), imaging and structural characterization (gross appearance, scanning electron microscopy, and transmission electron micros-
copy) and biomechanical testing. CSPCs have been used for cartilage repair in animal models with excellent outcomes that are comparable to
chondrocytes and superior to MSCs from unrelated tissue sources. The current review concludes that CSPCs represent a promising cell source for
cartilage tissue engineering, but there is currently no consensus on speciﬁc cell surface markers or isolation protocols.
VC 2019 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.5050814
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INTRODUCTION
Mesenchymal stem cells (MSCs) derived from adult tissues are a
promising cell type for tissue regeneration due to their self-renewal
capacity and ability to form multiple tissue types (Bianco, 2001).
Despite lacking intrinsic reparative ability due to its avascular, aneural,
and immune-privileged nature (Detterline et al., 2005; Cancedda,
2003; and Vinatier, 2009), articular cartilage has been shown to con-
tain a population of cells with progenitor-like qualities that are thought
to be involved in tissue homeostasis (Dowthwaite, 2004; Fickert, 2004;
Alsalameh, 2004; and Martin, 2003). In recent years, increasing evi-
dence suggests that they share many properties with MSCs, as deﬁned
by the International Society of Cellular Therapy (ISCT) (Dominici,
2006) such as adherence to plastic, self-renewal capacity, expression of
stem-cell-related surface markers, and multilineage potential, thus
functioning as bona ﬁde cartilage derived stem/progenitor cells
(CSPCs) (Williams, 2010; Quintin, 2010; Karlsson, 2009; Hattori,
2007; Hayes, 2008; Seol, 2012; Koelling, 2009; McCarthy, 2012; and
Jiang, 2015), similar to populations of stem cells found in many other
adult tissues (Brack, 2012 and Crisan, 2008).
Similarities in the characteristics of CSPCs and MSCs may be
related to the cartilage being a derivative of embryonic mesenchymal
cells, arising from various sources including the neuroectoderm (form-
ing the craniofacial skeleton), paraxial mesoderm (forming the axial
skeleton), and lateral plate mesoderm (forming long bones) (Olsen,
2000). The mesenchymal cells differentiate to form chondroblasts, and
subsequently chondrocytes, with concomitant secretion of extracellu-
lar matrix (ECM), characteristic of various stages of development
(Fig. 1). Findings suggest that at least two subpopulations of chondro-
genic cells coexist in the developing cartilage—multipotent cartilage
stem cells and oligopotent chondrogenic cartilage progenitor cells
(Wu, 2013)—but deﬁnitive differences between these subpopulations
in human adult cartilage have remained elusive. Evidence of reduced
adipogenicity despite successful osteogenic and chondrogenic induc-
tion (Alsalameh et al., 2004 and Grogan et al., 2009), low or no expres-
sion of RUNX2, the master transcription factor for chondrocyte
terminal differentiation, and enhanced expression of chondrocyte-
speciﬁc markers in chondroprogenitors (Seol et al., 2012) prevents the
synonymity of oligopotent cartilage progenitors and multipotent carti-
lage stem cells. While other reports suggest that cartilage progenitors
share more features with MSCs than chondrocytes, such as in vitro
self-renewal and trilineage differentiation, leading to a lack of consen-
sus in nomenclature (Levato et al., 2017 and Seol et al., 2012).
Chondrocytes secrete the cartilage extracellular matrix when cul-
tured in a 3D environment, but their dedifferentiation following
expansion has limited their widespread use in cartilage tissue engineer-
ing (Hamada et al., 2013 and Darling and Athanasiou, 2005). CSPCs
have been implicated in migration and tissue reparative activities in
response to native articular cartilage injury (Koelling, 2009 and Seol,
2012) and are identiﬁed as a promising renewable cell source for carti-
lage tissue engineering (Derks, 2013; Dowthwaite, 2004; Henriksson,
2009; and Kobayashi, 2011) due to their niche-speciﬁc lineage prefer-
ence for chondrogenesis (Pizzute, 2015 and Jansen, 2010). Unlike
hematopoietic stem cells, for example, which have a well-deﬁned pop-
ulation of cell-surface antigens to identify cellular immunophenotype
(Spangrude, 1998), CSPCs lack deﬁnitive, stable biomarkers, which
has made the developmental origin and correct puriﬁcation strategy of
these cells difﬁcult to elucidate (Jiang, 2015; Quintin, 2010; Lee, 2009;
and Diaz-Romero, 2005). To date, systematic reviews describing stem/
progenitor cells in cartilage have been lacking and their chondrogenic
capacity is debatable.
The purpose of this systematic review is to examine all the pub-
lished literature looking at progenitor and stem cells from different
cartilage types and summarize the available information about their
isolation and characterization to conclusively determine whether carti-
lage contains stem cells according to ISCT criteria (Dominici, 2006)
and provide clarity in nomenclature for future research in this ﬁeld.
This review will also assess the cartilage regenerative capacity of these
cells to determine their potential utility for cartilage tissue engineering.
METHODS
Search strategy
A systematic search for relevant articles was performed in accor-
dance with the recommendations of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher,
2015) to evaluate the isolation, characterization, and utilization of
CSPCs for cartilage tissue engineering. Preclinical studies of CSPC iso-
lation and characterization, in particular, with respect to plastic adher-
ence, cell surface markers, and multipotency, were identiﬁed through a
systematic search across electronic databases, Web of Science (Web of
Science Core Collection, BIOSIS Citation index, KCI-Korean Journal
Database, MEDLINE, and SciELO Citation Index), PubMed, and
Embase, from January 1947 to November 2017. Due to the varied
nomenclature of CSPCs, broad search terms were used which
included: “mesenchymal progenitor cells” AND cartilage OR “articular
cartilage”; “cartilage derived stem cells”; “perichondrial progenitor
cells”; “cartilage progenitor cells”; “chondroprogenitor cells”;
“chondrogenic progenitors”; “chondroprogenitors”; “cartilage stem
cells”; and “chondrogenic progenitor cells.”
Eligibility criteria
The inclusion criteria were studies that (1) involved the isolation
of cartilage stem/progenitor cells; (2) identiﬁed stem cells in adult ani-
mal or human cartilage; (3) assessed the regenerative capacity of carti-
lage stem/progenitor cartilage in vitro or in vivo; and (4) were of
English language articles only.
FIG. 1. Stages of cartilage development. Mesenchymal stem cell condensation
leading to chondrogenic differentiation and extracellular matrix (ECM) synthesis.
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Exclusion criteria
Studies were excluded if they (1) involved stem cells isolated
from noncartilaginous tissues; (2) identiﬁed stem cells in nonadults or
embryonic mesenchyme; and (3) were not available for viewing.
Review articles and commentaries were also excluded.
Study selection
Two reviewers (Jessop and Manivannan) independently screened
abstracts to identify studies meeting our inclusion criteria, with differ-
ences being resolved by the senior author (Whitaker). Titles were ini-
tially screened to exclude duplicates and further screened using the
abstracts against inclusion and exclusion criteria. Finally, a full text
review of the remainder was performed to assess their eligibility. The
bibliographies of relevant articles were studied to identify further rele-
vant publications (Fig. 2).
Data extraction andmain outcomes
Data were extracted from selected studies using a standardized
format (Microsoft Ofﬁce Excel 2016). The initial tabulated data collec-
tion included: cartilage source of CSPCs, species, isolation technique,
adherence to plastic, cell surface markers, and multipotency. Because
the surface markers for MSCs from other species have not been uni-
versally characterized, the ISCT criteria were also applied to both
human and nonhuman cartilage derived stem/progenitor cells
(Dominici, 2006). CSPC use for cartilage tissue engineering, including
scaffolds, signaling factors, and chondrogenicity (evidence for cartilage
formation at the gene, protein, structural, or biomechanical level) was
recorded. Also noted were study authors, study design (in vitro/in vivo
model), and the year of publication. Studies directly comparing the
chondrogenicity outcomes of CSPCs with other commonly used cell
sources such as chondrocytes and nontissue-speciﬁc MSCs were also
evaluated.
RESULTS
Study characteristics
Our search yielded 2071 results, and after the exclusion of dupli-
cates and preliminary screening 278 studies were identiﬁed for full text
review of which 65 fulﬁlled the eligibility criteria (Fig. 2). A total of 69
reports describing CSPC isolation in 65 preclinical studies were pub-
lished between 2004 and 2017. These reports involved the isolation of
adult animal or human cartilage stem/progenitor cells, and were all
either in vitro (n¼ 50), in vivo animal models (n¼ 13), or both
(n¼ 6), with no ﬁrst-in-human studies. Of the in vivo studies, the
majority of them used mice (n¼ 8), followed by rabbits (n¼ 5) and
rats (n¼ 3) with only individual studies using large animal models like
dogs, goats, monkeys, and horses.
FIG. 2. PRISMA ﬂow literature search summary diagram. The search identiﬁed a total of 2071 English articles. All the articles were screened and shortlisted according to the
inclusion and exclusion criteria. After initial screening, a total of 1189 abstracts were scrutinized, of which 278 abstracts were then further analyzed by retrieving the full text of
the articles. A total of 65 preclinical studies met the inclusion criteria.
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CSPC isolation
CSPCs were isolated from both articular (n¼ 40) and nonarticu-
lar cartilage (n¼ 29) sources (Tables I–III). Articular sources included
articular hyaline (n¼ 35) as well as meniscal (n¼ 5) cartilage (Tables I
and II). Nonarticular cartilage sources included intervertebral disk
(n¼ 11), auricular (n¼ 10), nasoseptal (n¼ 5), tracheal (n¼ 2), and
costal (n¼ 1) locations (Table III).
Various CSPC isolation and cell culture methods have been
adopted. Dowthwaite were the ﬁrst to use differential adhesion to ﬁbro-
nectin (Dowthwaite, 2004), and since then other studies have adopted
this technique mainly for the isolation of articular CSPCs (n¼ 15).
Other isolation methods include ﬂuorescence activated cell sorting based
on CSPC surface markers, magnetic cell separation as well as identifying
migratory and clonogenic subpopulations. Around half (14/29) of the
studies isolating nonarticular CSPCs do not have speciﬁc isolation tech-
niques and rely on simple tissue digest protocols of the perichondrial/
superﬁcial cartilage layer where CSPCs are believed to reside.
CSPC characterization
Of the 69 reports on isolating CSPCs, 53 assessed their cell sur-
face marker expression and 48 assessed their potential to differentiate
into additional lineages, namely osteogenic and adipogenic. CD90,
CD105, CD44, CD166, CD73, and CD29 were the most common pos-
itive cell surface markers for CSPCs across different cartilage locations
(Table IV), and the most commonly studied negative markers were
CD34 and CD45 (Table V). CSPCs were reported to be positive for
HLA-ABC, but lack expression of HLA-DR (Tables IV and V). The
only conﬂicting results were for CD133 cell surface marker expression,
wherein four studies found it to be positive in articular (Yu, 2014),
nasoseptal (Shaﬁee, 2011), and IVD CSPCs (Risbud, 2007 and Liu,
2011) and ﬁve studies found it to be negative in articular (Joos, 2013
and Su, 2015), auricular (Kobayashi, 2011), and nasoseptal (Shaﬁee,
2014 and Elsaesser, 2015) CSPCs.
Of the 48 studies that assessed differentiation, only 8 reported
failure to differentiate into either adipogenic or osteogenic lineages,
with 75% conﬁrming trilineage potential for CSPCs. Only 35% (24/69)
reports on CSPCs met the ISCT deﬁnition of MSCs due to partial
mesenchymal-lineage differentiation potential, most commonly chon-
drogenic and osteogenic, but failure of adipogenic potential or the lack
of immunophenotyping data, particularly assessing for negative CD
markers, which left the identity of CSPCs in doubt (Table VI). For
instance, Seol (2017) isolated ﬁbroblast-like clonogenic cells from
bovine meniscal cartilages that exhibited multilineage (chondrogenic,
osteogenic, and adipogenic) potential and plastic adherence, but lack
of immunophenotype data means their MSC status was not con-
ﬁrmed. Most commonly, there was a simultaneous lack of both immu-
nophenotype and multilineage data implying that these studies did not
attempt to fully characterize CSPCs according to ISCT criteria follow-
ing isolation rather than actively disproving that they are not adult
derived stem cells.
CSPCs for cartilage regeneration
Four cartilage regenerative outcomes were assessed by this
review, namely chondrogenic gene and protein expression [including
quantitative polymerase chain reaction (qPCR), histology, immuno-
histochemistry, and biochemistry], imaging and structural
characterization (gross appearance, SEM, and TEM) and biomechani-
cal testing. The most common chondrogenesis protocols consisted of
pellet culture with TGFb1, TGFb3, or FGF2. Most studies showed that
after chondrogenic induction, CSPCs not only had increased expres-
sion of chondrogenic genes but also secreted cartilage extracellular
matrix in vitro and in vivo, speciﬁc to their cartilage subtype origin,
i.e., hyaline (McCarthy, 2012; Yoon, 2013; Williams, 2010; and
Anderson, 2017) or elastic (Kobayashi, 2011; Takebe, 2012; and
Kagimoto, 2016).
One study reported elastic auricular cartilage CSPCs being able
to regenerate hyaline-like articular cartilage in an animal model
(Mizuno, 2014), suggesting plasticity between cartilage subtypes.
While three studies found evidence to support ﬁbrocartilage rather
than functional hyaline articular cartilage formation (Dowthwaite,
2004 and Koelling, 2009) or elastic auricular cartilage formation
(Derks, 2013). Only four studies assessed tissue engineered cartilages’
biomechanical properties (Levato, 2017; Anderson, 2017; Shen, 2013;
and Mizuno, 2014), despite this being a prerequisite for determining
their clinical utility (Gleghorn, 2007 and Roy, 2004). Articular and
meniscal cartilage studies assessed compressive stiffness using either
unconﬁned uniaxial compression testing (Levato, 2017 and Anderson,
2017) or indentation testing (Shen, 2013). Auricular cartilage elasticity
and stiffness were determined by nano(indentation) using atomic
force microscopy, with the resulting engineered cartilage from auricu-
lar CSPCs more closely matching the mechanical properties of hyaline
rather than elastic cartilage (Mizuno, 2014).
Chondrogenesis of CSPCs vs other cell types
CSPC chondrogenicity was directly compared with other cell
types, most commonly chondrocytes (n¼ 21) and bone marrow
(n¼ 21), adipose (n¼ 4), and synovium (n¼ 2) derived MSCs. MSCs
were found to have increased expression of osteogenic genes resulting
in hypertrophic cartilage formation (McCarthy, 2012; Su, 2015; and
Shen 2014) compared to CSPCs which exhibited a greater tendency
for chondrogenic differentiation (Ding and Huang, 2015; Shaﬁee,
2011; Baptista, 2013; Togo, 2006; Derks, 2013; Xue, 2015; Liu, 2011;
Shi, 2015; and Derks, 2013), with only one study suggesting compara-
ble results (Alsalameh, 2004). Chondrocytes, on the other hand, were
either comparable (Elsaesser, 2016; Togo, 2006; Kobayashi, 2011; and
Williams, 2010) or superior to CSPCs (Seol, 2017; Marcus, 2014; and
Zhou, 2014) in their chondrogenic differentiation potential, with only
one study suggesting inferior results (Levato, 2017).
In vivo application of CSPCs for cartilage repair
Of the 19 in vivo animal models assessing the use of CSPCs for
cartilage regeneration toward tissue engineering applications, most
used CSPCs isolated from articular hyaline (n¼ 6), auricular (n¼ 6),
and meniscal (n¼ 3) sources, reﬂecting clinical need for cartilage
repair in those locations (Table VII). Clinical disease models for poten-
tial future utility of CSPCs included osteoarthritis, degenerative disk
disease, as well as facial, tracheal, and thorax reconstruction following
trauma, tumor, degeneration, and congenital conditions resulting in
cartilage defects (Table VII). 90% of studies demonstrated the capabil-
ity of CSPCs for generating the cartilage matrix in vivo, both in xeno-
and auto-transplantation animal models, conﬁrmed using histology,
immunohistochemistry, SEM, TEM, and magnetic resonance imaging
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TABLE I. Cartilage derived stem/progenitor cells (CSPCs) from articular hyaline cartilage. MACS, magnetic cell separation; O, osteogenic differentiation; A, adipogenic differentiation; C, chondrogenic differentia-
tion; N, No; Y, Yes; TGFb1/2/3, transforming growth factor b1/2/3; OA, osteoarthritis; rtPCR, reverse transcriptase polymerase chain reaction; Col1/2/10, collagen type 1/2/10; Agg, aggrecan; GAG, glycosamino-
glycans; COMP, cartilage oligomeric matrix protein; SafO, Safranin O; AB, Alcian blue; TB, toluidine blue; Sox9, SRY-Box 9; MSC, mesenchymal stem cell; BMSC, bone marrow derived mesenchymal stem cell;
TEM, transmission electron microscopy; SEM, scanning electron microscopy; SDF1, stromal cell-derived factor 1; FACS, ﬂuorescence activated cell sorting; IHC, immunohistochemistry; BMP2/6/7, bone morpho-
genetic protein 2/6/7; ICRS, International Cartilage Repair Society; ECM, extracellular matrix; DMMB, 1,9-dimethyl-methylene blue assay; HSA-HA, human serum albumin/hyaluronan; IVD, intervertebral disk;
SCID, severe combined immunodeﬁciency; FGF2, ﬁbroblast growth factor 2; IL1b, interleukin 1 beta.
Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency
ISCT
criteria
In vitro/
in vivo
Chondrogenic
induction Control groups
Evidence for
cartilage
regeneration Outcome
Alsalameh
(2004)
Human MACS (CD105þ
CD166þ)
Y CD105þ, CD166þ O, A. C Y In vitro Micromass,
TGFbl/3
BMSCs OA and
non-OA CSPCs
GAG (AB)
Col1, Col2. Agg
(IHC)
Cartilage formation with
CSPCs comparable to
MSCs
Dowthwaite
et al. (2004)
Bovine Fibronectin
adhesion
Y CD29þ, CD49eþ,
Notch-1
C,O N In vitro,
in vivo
(ovine)
Injection into the
proximal limb of
chick embryo
… Col1 (IHC) Tissue-speciﬁc matrix syn-
thesis in ovo
Fickert
et al. (2004)
Human FACS (CD9þ
CD90þCD1 66þ)
Y CD9þ, CD44þ,
CD54þ, CD90þ,
CD166þ
O, A, C N In vitro Pellet, TGFb3 BMSCs,
chondrocytes
Col1, Col2,
COMP (IHC)
GAG (AB)
Dense cartilage nodules in
triple positive CSPCs
Martin
et al. (2005)
Bovine Fibronectin
adhesion
Y … C N In vitro Pellet, TGFb1 þ/ TGFbl GAG (SafO)
Col2 (IHC)
CSPCs are able to produce
cartilage ECM after pro-
longed expansion and
cryopreservation
Thornemo
et al. (2005)
Human Agarose suspension N … C N In vitro 3D agarose Different types of
cell clusters
GAG (Safo)
Col2, Agg
(IHCQ
CSPCs likely form homoge-
nous matrix clusters
Hattori
et al. (2007)
Bovine FACS (Hoechst
33342 side
population)
Y ABCG2þ C N In vitro Micromass,
BMP7 and
TGFb1
Untreated CSPCs GAG (TB) Col2
(IHC)
Growth factor treatment of
CSPCs resulted in increased
GAG and Col2 synthesis
Ustunel
et al. (2008)
Human Fibronectin
adhesion
Y Notch-1þ, Notch-
2þ, Deltaþ,
Jagged-1þ
C N In vitro Pellet Chondrocytes TEM. SEM CSPCs formed larger colo-
nies than chondrocytes,
rounded phenotype
Grogan
et al. (2009)
Human FACS (Hoechst
33342 side
population)
Y CD44þ, CD90þ,
CD105þ, CD166þ,
Stro-1þ, Notch-
1þ, CD106þ,
ABCG2þ
O, C, not A N In vitro Pellet, TGFb1 Non side popula-
tion cells
Col1, Col2,
Agg, Sox9
(rtPCR) GAG
(SafO)
>45% cells in normal carti-
lage positive for MSC
markers. CSPCs higher
GAGs and chondrogenic
gene expression
Khan et al.
(2009)
Bovine Fibronectin
adhesion
Y Notch-1þ C N In vitro Pellet, TGFb1 Chondrocytes GAG (SafO)
Age (IHC)
CSPCs have higher telome-
rase activity and coordi-
nated cartilage growth
Koelling
et al. (2009)
Human Migratory
subpopulation
Y CD29þ, CD44þ,
CD73þ, CD90þ,
CD105þ, Stro-1þ,
CD45, CD17
O, A, C Y In vitro 3D alginate,
TGFb3 and
BMP6
Chondrocytes and
osteoblasts
Sox9, Col2
(ISH)
3D culture alone sufﬁcient
for CSPC chondrogenesis,
but enhanced by growth
factors and runx-2 knock-
out, unclear if ECM is bet-
ter than OA ﬁbrocartilage
Williams
et al. (2010)
Human
and
Caprine
Fibronectin
adhesion
Y CD105þ, CD166þ,
CD44þ, CD29þ,
CD49eþ, Notch-
1þ, CD90þ, Stro-
lþ, Jagged-1þ,
Delta-1þ
A, C, limited O N In vitro/
in vivo
(caprine)
Pellet, TGFb3 &
caprine articular
defect
Chondrocytes GAG (TB,
SafO) Col1 &
Col2 (IHC)
CSPCs capable of cartilage
formation in vitro and
in vivo. Comparable ICRS
scores for CSPCs and
chondrocytes.
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TABLE I. (Continued.)
Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency
ISCT
criteria
In vitro/
in vivo
Chondrogenic
induction Control groups
Evidence for
cartilage
regeneration Outcome
Chang et al.
(2011)
Human MACS
(CD105þCD166þ)
Y CD105þ, CD166þ O, C N In vitro TGFb1 CSPCs from fetus,
adults, and elderly
Agg, Col2
(rtPCR)
Lower chondrogenic and
higher osteogenic differen-
tiation of CSPCs from
elderly adults
Pretzel
et al. (2011)
Human MACS (CD166þ) Y CD105þ, CD166þ O, A, C N In vitro Pellet, TGFb3 CD166þ enriched
and depleted
GAG (AB) CD166þ enriched CSPCs
showed stronger chondro-
genic phenotype. Suggested
CSPC niche in superﬁcial
and middle zones
McCarthy
et al. (2012)
Equine Fibronectin
adhesion
Y CD90þ, CD166þ,
Stro-Iþ, Notch-1þ
O, A, C N In vitro Pellet, TGFbl BMSC Agg. Col2.
Runx2,
Matrillin-
1(IHC)
CSPCs formed functional
rather than hypertrophic
cartilage of BMSCs
Seol et al.
(2012)
Bovine and
human
Migratory
subpopulation
Y ABCG2þ, Notch-
1þ, CD44þ
O, C, limited A N In vitro Pellet, TGFbl Chondrocytes and
BMSCs
GAG (SafO)
Microarray
Migratory CSPCs have
higher expression of chon-
drogenic genes than MSCs
and may contribute to car-
tilage repair (chondrocyte
> CSPC >MSC)
Benz et al.
(2013)
Human MACS (W5C5þ) Y CD49eþ, CD73þ,
CD90þ, CD105þ,
CD140bþ,
CD166þ, CD34,
CD45, CD271
C but limited O
and A
N In vitro 3D HSA-HA
hydrogel, TGFb3
W5C5 enriched
and depleted, IVD
CSPCS
Sox9. Col2
(rtPCR) GAG
(DMMB)
CSPC chondrogenesis even
after prolonged expansion;
W5C5 and W8B2 were not
exclusively required for
chondrogenicity
Bernstein
et al. (2013)
Human Enzymatic digest
and
dedifferentiation
Y CD9þ, CD44þ,
CD54þ, CD73þ,
CD105þ, CD166þ,
CD 45
O, C N In vitro Pellet, TGFb3 CSPCs from differ-
ent OA grades
GAG (DMMB) CSPCs maintained capacity
to be reprogrammed into
chondrocytes after
passage 4
Joos et al.
(2013)
Human Migratory
subpopulation
Y CD29þ, CD44þ,
CD73þ, CD90þ,
CD105þ, CD166þ,
CD54þ, MSCA-
1þ, Stro-lþ,
CD88þ, CD34þ,
CD133, CD45
O, A, C Y In vitro Micromass BMSC Sox9,Col2, Coll,
Agg, COMP
(rtPCR) Col2.
COMP (IHC)
Chondrogenic medium was
required for CSPCs to form
cartilage in vitro
Singh et al.
(2013)
Rabbit Differential plastic
adherence
Y CD106þ, CD44þ C N In vivo
(rabbit)
Pellet, subchon-
dral drilling, then
CSPCs in 3D col-
lagen to ﬁll artic-
ular defect in
rabbits
Subchondral dril-
ling alone
Col2.Ag
(rtPCR) GAG
(TB, ICRS).
Arthroscopy,
radiology, and
SEM
CSPC group is superior to
control after 15 days and
reduced the tide mark,
thereby reducing the
chance of osteophytes
Marcus
et al. (2014)
Bovine Fibronectin
adhesion
Y … C N In vivo
(mouse)
Injection into
SCID
Chondrocytes Col2, Sox9
(rtPCR) Sox9
(IHC) GAG
(AB. SafO)
CSPCs maintain chondro-
genic potential, but fail to
form functional matrix
in vivo
Nelson
et al. (2014)
Human Fibronectin
adhesion
Y Stro-lþ O, A, C N In vitro Pellet, TGFb2 … Sox9, Col2. Agg
(rtPCR) GAG
(SafO, TB)
Col2, Agg
(IHC)
Clonal variation in the
degree of differentiation
suggests further subpopula-
tions of CPSCs
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TABLE I. (Continued.)
Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency
ISCT
criteria
In vitro/
in vivo
Chondrogenic
induction Control groups
Evidence for
cartilage
regeneration Outcome
Ozbey et al.
(2014)
Human Fibronectin
adhesion
Y CD90þ, CD105þ,
CD166þ, Stro-lþ
O, A, C N In vitro Pellet, TGFbl … GAG (IHC) CSPCs were also present in
deep zones and continued
to express stem cell markers
and were able to form carti-
lage in vitro after 3 passages
Zhou et al.
(2014)
Bovine Migratory
subpopulation
Y … C N In vitro Pellet, TGFbl Chondrocytes and
synovial ﬁbroblasts
GAG (DMMB)
Microarray
Chondrocytes showed sig-
niﬁcantly higher expression
of ECM genes and GAGs
than CSPCs (ch
ondrocyte>CSPC>Synovi-
al ﬁbroblast
Yu et al.
(2014)
Bovine FACS (single cell
sorting) and
clonogenicity
Y ABCG2þ,
CD133þ, CD105þ,
CD90þ, CD71þ,
CD29þ, Notch 1þ
O, C, limited A N In vitro Pellet, TGFbl CSPCs from differ-
ent zones
Sox9, Col2
(rtPCR) GAG
(SatO)
Deep zone CSPCs are more
chondrogenic than
superﬁcial
Frisbie
et al. (2015)
Equine Fibronectin
adhesion
Y … C N In vivo
(horse)
3D ﬁbrin, TGFbl
and FGF2
injected into
horse articular
defect
Autologous vs allo-
genic CSPCs
GAG (SafO)
Coll, Col2
(IHC) arthros-
copy, and
radiography
Autologous CSPCs superior
to control (6 and 12 m)
Jiang and
Tuan
(2015)
Human NGF cell migration
assay
Y CD271þ, CD90þ,
CD73þ, CD105þ,
CD166þ, CD44þ,
CD29þ, CD34,
CD45
O, A, C Y In vitro Pellet, TGFb3 Chondrocytes Coll, Col2. Agg,
Sox9 (rtPCR)
GAG (Safo)
CSPCs formed cartilage
matrix in vitro, reduced by
nerve growth factor
treatment
Neumann
et al. (2015)
Human Fibronectin
adhesion
Y Notch-1þ C N In vitro 3D ﬁbrin and
polyurethane,
BMP2, and
mechanical
stimulation
No mechanical
stimulation/BMP2
overexpression
Coll, Col2. Agg
(rtPCR) No
GAG
Chondrogenic genes
increased by mechanical
stimulation, but hypertro-
phic genes increased by
BMP2
Su et al.
(2015)
Human FACS (CD146þ) Y CD146þ, CD44þ,
CD73þ, CD90þ,
CD105þ, HLA-
ABCþ, CD34,
CD45, CD 133
O, A, C Y In vitro Pellet Chondrocytes and
adipose MSCs
Sox9, Agg, Col2
(rtPCR) GAG
(TB)
Col2.Aeg.Sox9
(IHC)
CSPCs showed higher
chondrogenic capacity than
adipose MSCs
Tong et al.
(2015)
Rat Fibronectin
adhesion
Y CD44þ, CD90þ,
CD31, CD34,
CD45
O, A, C Y In vitro and
in vivo (rat)
Pellet, TGFb1,
and IL1b
Chondrocytes and
BMSCs
Agg, 5ox9, Col2
(rtPCR) GAG
(AB)
TGFb1 induced and IL1b
suppressed CSPC chondro-
genesis in vitro
Xue et al.
(2015)
Porcine Fibronectin
adhesion
Y CD29þ, CD44þ,
CD90þ, CD34,
CD35
O, A, C Y In vitro 2D monolayer
and pellet, TGFbl,
and FGF2
BMSCs, auricular/
IVD CSPCs
Agg, Col2,
COMP (rtPCR)
GAG (AB)
Col2 (IHC)
CSPCs increased the
expression of chondrogenic
genes than BMSCs
Li et al.
(2016)
Rabbit Fibronectin
adhesion
Y CD90þ, CD105þ,
CD166þ, CD34,
CD45
O, A, C Y In vitro 3D alginate beads
with mechanical
stimulation
Chondrocytes and
fat pad derived
stem cells
GAG (SafO St
DMMB) Col2
(IHC)
Mechanical stimulation
increased chondrogenesis
in CPSCs more than
controls
Zhao
(2016)
Rat Clonogenicity Y CD29þ, CD49eþ,
CD90þ, CD73þ,
CD146þ. CD45
O, A. C Y In vitro 3D alginate,
TGFb3, and
BMP 6
Chondrocytes GAG (AB)
Col1. Col2
(IHC)
Leptin inhibits chondro-
genesis by C5PCs and
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(MRI). One study reported that CSPCs were unable to produce carti-
lage matrix in vivo unlike chondrocytes, despite their expression of
chondrogenic genes (Marcus, 2014). Of the studies involving other cell
types, CSPCs were found to generate cartilage matrix superior to
nontissue-speciﬁc MSCs (Ding and Huang, 2015; Wang, 2014; and
Togo, 2006), but comparable to chondrocytes (Williams, 2010 and
Togo, 2006), thereby conﬁrming in vitro ﬁndings.
DISCUSSION
To the best of our knowledge, this systematic review is the ﬁrst
to comprehensively summarize the available evidence on cartilage
derived stem/progenitor (CSPC) isolation and cartilage regenera-
tive capacity to determine suitability for tissue engineering. Based
on the reported studies, CSPCs exist in both adult animal and
human cartilages, with the articular hyaline cartilage being the ear-
liest and most well-studied source to date. Increasing evidence sug-
gests the existence of CSPCs in other types of cartilages, including
the intervertebral disk, auricular, nasoseptal, tracheal, and costal, in
the order of decreasing frequency and across a variety of species.
CSPCs have been used for cartilage repair in vivo with excellent
outcomes that are comparable to chondrocytes and superior to
MSCs from unrelated tissue sources. The current review concludes
that CSPCs represent a promising cell source for cartilage tissue
engineering, but there is currently no consensus on speciﬁc cell sur-
face markers or isolation protocols.
CSPCs were initially described to reside in the superﬁcial zone of
articular cartilage (Dowthwaite, 2004 and Williams, 2010), and this
view has been supported by successful isolation of CSPCs from auricu-
lar perichondrium (Kobayashi, 2011 and Takebe, 2012), superﬁcial
zone of nasoseptal cartilage (do Amaral, 2012 and Baptista, 2013), as
well as tracheal (Yoon, 2013) and costal (Srour, 2015) perichondrium.
It is believed that the surface location of CSPCs allows them to
respond to soluble factors released into the synovium or blood during
injury in order to coordinate in vivo cartilage repair. However, other
studies refute this theory and have also found CSPCs in deeper zones
of cartilage (Ozbey, 2014 and Yu, 2014).
Our results indicate that despite the heterogeneity in CSPC
isolation methods, cell surface marker expression proﬁles are con-
sistent across different studies and cartilage types. CSPCs are posi-
tive for recognized MSC markers CD90, CD105, CD44, CD166,
CD73, and CD29 and negative for hematopoietic markers CD34
and CD45, with the only conﬂicting data existing for CD133. This
is unlike adult MSCs from other tissue sources which tend to have
heterogeneous cell surface marker expression proﬁles with conﬂict-
ing data between studies (Maﬁ, 2011). This suggests that CSPCs
represent a relatively homogenous population of cells which could
be attributed to the lack of contaminating cell populations with the
cartilage being recognized as avascular, aneural, and immune
privileged.
Despite the relative overlap in cell surface markers between
articular, meniscal, auricular, nasoseptal, tracheal, and perichondral
CSPCs, those isolated from the intervertebral disk do express some
unique neuronal stem and progenitor cell associated surface
markers. These include p75NTR (neurotrophin receptor) (Risbud,
2007), nestin (Feng, 2010), neuron-speciﬁc enolase (Feng, 2010),
and GD2 (neural ganglioside) (Sakai, 2012). This is likely attributed
to the intervertebral disk being a multicomponent structure andTA
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TABLE II. Cartilage derived stem/progenitor cells (CSPCs) from the meniscal cartilage. MHC-II, major histocompatibility complex class II; O, osteogenic differentiation; A, adipogenic differentiation; C, chondro-
genic differentiation; N, No; Y, Yes; TGFb1/3, transforming growth factor b1/3; OA, osteoarthritis; rtPCR, reverse transcriptase polymerase chain reaction; Col1/2/10, collagen type 1/2/10; GAG, glycosaminogly-
cans; SafO, Safranin O; Sox9, SRY-Box 9; MSC, mesenchymal stem cell; BMSC, bone marrow derived mesenchymal stem cell; TEM, transmission electron microscopy; SDF1, stromal cell-derived factor 1;
and FACS, ﬂuorescence activated cell sorting.
Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency
ISCT
criteria
In vivo/
in vitro
Chondrogenic
induction
Control
Group
Evidence of
cartilage
regeneration Outcome
Shen et al.
(2013)
Rabbit Clonogenicity Y MHC-II O, A, C N In vivo
(rabbit)
Pellet, TGFbl, injec-
tion postmeniscec-
tomy/OA rabbits
PBS Col 2 (rtPCR)
GAG (SafO)
biomechanical,
radiological
CSPCs were able to regen-
erate the meniscal cartilage
and prevent OA
Muhammad
et al. (2014)
Human Migratory
subpopulation
Y Strolþ, CD29þ,
CD90þ CD105þ.
CD106þ, CD45,
CD34
O, A, C Y In vitro 3D Alginate.
TGFb3
Chondrocytes Sox9, Col2
(Western)
CSPCs’ ability to regenerate
cartilage may be inhibited
by mediators of inﬂamma-
tion in OA
Shen et al.
(2014)
Human Clonogenicity Y CD44þ, CD90þ,
CD105þ, CD166þ,
CD34, CD45
O, A, C Y In vitro and
in vivo (rat)
Injected into rats
with meniscal
defect
Synovial MSCs
and BMSCs
GAG (SafO)
Col1, Col2,
Col10 (IHC)
TEM
CSPCs express higher colla-
gen 2 levels than controls
in vitro and meniscal regen-
eration in vivo via SDF1
mediated migration
Ding and
Huang (2015)
Rabbit Clonogenicity Y SSEA-4þ, CD44þ,
CD90þ, Stro-1,
CD34
O, A, C Y In vitro and
in vivo (nude
rat)
Pellet, TGFb3, and
implanted in rats
on 3D matrigel
BMSCs GAG (SafO)
Col2 (Western)
CSPCs exhibited greater
tendency to chondrogenic
differentiation than con-
trols in vitro and in vivo
Seol (2017) Bovine FACS (Hoechst
33342 side
population)
Y ABCG2þ O, A, C N In vitro Pellet, TGFbl Chondrocytes GAG (SafO)
Microarray
CSPCs underexpress carti-
lage extracellular matrix
components compared to
chondrocytes
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TABLE III. Cartilage derived stem/progenitor cells (CSPCs) from nonarticular cartilage sources. MSC, mesenchymal stem cell; BMSC, bone marrow derived mesenchymal stem cell; O, osteogenic differentia-
tion; A, adipogenic differentiation; C, chondrogenic differentiation; N, No; Y, Yes; TGFb1/3, transforming growth factor b1/3; FGF2, ﬁbroblast growth factor 2; IGF1, insulin growth factor 1; BMP2, bone morphoge-
netic protein 2; EGF, epidermal growth factor; PLLA/PCL, Poly L-lactide/Polycaprolactone; rtPCR, reverse transcriptase polymerase chain reaction; Col1/2/10, collagen type 1/2/10; Agg, aggrecan; GAG,
glycosaminoglycans; COMP, cartilage oligomeric matrix protein; SafO, Safranin O; AB, Alcian blue; TB, toluidine blue; H&E-hematoxylin and eosin stain; Sox9, SRY-Box 9; TEM, transmission electron micros-
copy; SEM, scanning electron microscopy; IHC, immunohistochemistry; DMMB, 1,9-dimethyl-melthylene blue assay; EVG, elastic van Gieson; FACS, ﬂuorescence activated cell sorting; MACS, magnetic cell
separation; ECM, extracellular cartilage matrix; SCID, severe combined immunodeﬁciency; HUVEC, human umbilical vein endothelial cell; IVD, intervertebral disk; CEP, cartilage endplate; NP, nucleus pulposus;
AF, annulus ﬁbrosus; HSA-HA, human serum albumin/hyaluronan; and pCT, X-ray microtomography.
Cartilage
type Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency ISCT
In vitro/
in vivo
Chondrogenic
induction
Control
groups
Evidence of
cartilage
regeneration Outcome
Nasoseptal Shaﬁee et al.
(2011)
Human Clonogenicity Y CD90þ, CD105þ,
CD106þ, CD166þ,
HLA-ABCþ, CD133þ.
CD34, CD45, HLA-
DR
O, C, N Y In vitro Pellet BMSCs and
adipose derived
MSCs
GAG (SafO)
Cot 2 (IHC)
CSPCs demon-
strated higher
chondrogenic
potential than
controls
do Amaral et al
(2012)
Human Superﬁcial zone
digest
Y CD44þ, CD73þ,
CD105þ, CD146
O, C, not A N In vitro Pellet … SOX9 (rtPCR)
GAG (SafO)
CSPCs capable of
chondrogenic dif-
ferentiation even in
the absence of
growth factors
Baptista et al.
(2013)
Human Superﬁcial zone Y … C N In vitro Pellet, TGFb3 Adipose
derived MSCs
GAG (SafO)
Col2 (IHC)
CSPCs able to
regenerate mature
ECM unlike con-
trols even without
growth factors
Shaﬁee et al.
(2014)
Human Clonogenicity Y CD73þ, CD90þ,
CD105þ, CD106þ,
CD166þ, HLA-ABCþ,
CD34, CD45,
CD133, HLA-DR
O, A, C Y In vitro 3D PLLA/PCL,
TGFbl
Aligned vs ran-
domly oriented
nanoﬁbers
Agg, Col2
(rtPCR) Col2
(IHC) SEM
Successful cartilage
formation by
CSPCs on aligned
ﬁbers
Elsaesser et al.
(2016)
Human Migratory
subpopulation
Y CD29þ, CD44þ,
CD105þ, CD106þ,
CD90þ, CD34,
CD133, CD45,
CD31
O, C N In vitro 3D decellular-
ized ECM
BMSCs and
chondrocytes
GAG (DMMB.
AB) Col10,
Col2 (IHC)
CSPCs migrated
faster into scaffold
but cartilage syn-
thesis was compa-
rable to
chondrocytes
Auricular Togo et al.
(2006)
Rabbit Clonogenicity Y … O, A,C N In vivo
(mouse)
Pellet, then
seeded on 3D
collagen and
injected dor-
sally in nude
mice
Chondrocytes
and BMSCs
Col 2. Agg
(rtPCR) GAG
(TB) Elasti n
(EVG) Col1,
Col2 (IHC)
CSPCs from pas-
sage 3 regenerated
the same amount of
carti1age as chon-
drocytes but more
than BMSCs
Kobayashi et al.
(2011) (i)
Human Perichondrium
digest and FACS
(CD44þCD90þ)
Y CD44þ, CD90þ,
CD49eþ, CD73þ, CD
105þ, CD34,
CD24, CD117,
CD133. CD138,
CD140a, CD146,
CD271
C N In vivo 2D layers,
FGF2 and
IGF1. injected
SCID mice
Chondrocytes GAG (AB. TB.
SafO) Col10,
Col2 (IHC)
ECM (ELISA)
CSPCs demon-
strated similar car-
tilage regenerative
abi1ity In vitro and
in vivo as controls
Kobayashi
et al2011 (ii)
Murine Perichondrium
digest
Y CD44þ, CD49eþ C N In vitro 2D Dermal
ﬁbroblast
GAG (AB) CSPCs have greater
GAG secretion
than controls
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TABLE III. (Continued.)
Cartilage
type Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency ISCT
In vitro/
in vivo
Chondrogenic
induction
Control
groups
Evidence of
cartilage
regeneration Outcome
Takebe et al.
(2012)
Human Perichondrium
digest
Y … C N In vitro 2D layers,
FGF2 Sc IGF1,
3D collagen/
hydroxyapatite/
chondroitin
sulfate scaffold
Noncell seeded
scaffold only
GAG (AB) ifas-
tin (EVG)
CSPCs formed elas-
tic cartilage in a
bioreactor
Derks et al.
(2013)
Porcine Perichondrium
digest
Y … O, A, C N In vitro Pellet. FGF2 Sc
TGFbl
Tracheal
CSPCS and
BMSCs
Col 2. Agg.
COMP. Coll
(rtPCR) GAG
(AB) Col2
(IHC)
CSPCs demon-
strated higher
chondrogenesis
than Controls, but
failed to generate
elastin
Sterodimas and
de Faria (2013)
Rabbit Perichondrium and
decell hNP chon-
drium digest
Y … C N In vivo
(rabbit0
Pellet, TGFb3
and BMP2,
Seeded on 3D
alginate/silk,
implanted sack
of rabbit
CSPCs from
chondrium and
perichondrium
GAG (AB)
Macroscopic
measurements
Formation of carti-
lage with auricular
morphology, size,
and ﬂexibility after
8weeks
Mizuno et al.
(2014)
Canine Perichondrium
digest
Y CD44þ, CD90þ C N In vivo
dog)
2D monolayer.
IGF1 and
FGF2, cell clus-
ters injected
into canine
articular defect
With and with-
out ﬁbrin glue
GAG (DMMB.
AB) Col1, Col2
(IHC)
biomechanical
Formation of carti-
lage similar to hya-
line and stiffer than
auricular cartilage
after 60 days
Takebe et al.
(2014)
Human Perichondrium
digest
Y … C N In vivo
(mouse)
Co-cultured
with HUVECs,
transplanted
into the cranial
window of
SCID mice
Conventional
pellet culture
GAG (AB)
Elastin (EVG)
Col1, Col2 Agg
(IHC)
Formation of carti-
lage superior with
condensed progeni-
tors and HUVEC
co-culture
Xue et al.
(2015)
Porcine Fibronectin
adhesion
Y CD29þ, CD44þ,
CD90þ, CD34, CD
35
O, A, C Y In vitro Pellet, TGFbl
and FGF2
BMSC, IVD/
articular CSPCs
Col2, Agg,
COMP (rtPCR)
GAG (AB)
Col2 (IHC)
CSPCs have
increased expres-
sion of chondro-
genic genes than
BMSCs
Kagimoto
(2016)
Monkey
and human
Perichondrium
digest
Y … O, A, C N In vivo
(mouse and
monkey)
FGF2 8c
Insulin, trans-
planted subcu-
taneous and
cranio-facial
Human and
monkey CSPCs
GAG (AB)
Elastin (EVG)
Col1, Col2
(IHC) MRI
Elastic cartilage for-
mation in vitro and
in vivo
IVD Risbud et al.
(2007)
Human
and rat
Clonogenicity Y CD90þ, CD73þ,
p75NTR, CD105þ,
CD166þ, CD63þ,
CD493þ, CD133þ,
CD34, CD45
O, A. C Y In vitro Pellet, TGFb3 3D alginate
culture
Sox9, Col2. Agg
(rtPCR) 5AG
(AB)
AF and NP CSPCs
capable of chondro-
genic
differentiation
Blanco et al.
(2010)
Human Clonogenicity Y CD90þ, CD73þ,
CD105þ, CD166þ,
CD106þ, C034,
CD45, CD14,
CD19, HLA-DR
O, C not A N In vitro Pellet BMSCs GAG (TB) NP CSPCs capable
of chondrogenic
differentiation
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TABLE III. (Continued.)
Cartilage
type Study Species
Isolation
technique
Plastic
adherence
Cell surface
markers Multipotency ISCT
In vitro/
in vivo
Chondrogenic
induction
Control
groups
Evidence of
cartilage
regeneration Outcome
Feng et al.
(2010)
Human Migratory
subpopulation
Y CD29þ, CD49eþ,
CD51þ, CD73þ,
CD90þ, CD105þ,
CD166þ, CD184þ,
Stro-lþ, Nesting
Neuron speciﬁc
enolaseþ
O, A, C N In vitro Pellet … Sox9, Col2, Agg
(rtPCR) GAG
(AB)
AF CSPCs capable
of chondrogenic
differentiation
Liu et al. (2011) Human Agarose suspension N CD1Q5þ, CD73þ,
CD90þ CD44þ,
CD166þ. Stro-lþ,
CD133þ, CD14,
CD34, CD19,
CD45
O, A, C Y In vitro 3D agarose,
pellet, TGFb3
BMSCs Col 2, Agg,
Sox9 (rtPCR)
GAG (TB, AB)
Agg, Col2
(IHC)
CEP CSPCs exhib-
ited superior chon-
drogenesis to
controls
Sakai et al.
(2012)
Human
and mouse
FACS (Tie2þ) Y Tie2þ, GD2þ, CD44þ,
CD49fþ, CD56þ,
CD73þ, CD90þ,
CD105þ, 166þ
O, A, C Y In vitro and
mouse)
3D methyl cel-
lulose or decell
hNP, trans-
planted into
SCID mice
Chondrocytes GAG (SafO.
TB) Col2, Agg
(IHC)
NP CSPCs capable
of extracellular
matrix synthesis
in vitro and in vivo
but frequency
reduces with age
and IVD
degeneration
Xiong et al.
(2012)
Human Agarose N CD73þ, CD90þ,
CD105þ, CD14,
CD19, CD34,
CD45, HLA-DR
O, A, C Y In vitro Pellet, TGFb3 þ/ macro-
phage inhibi-
tory factor
GAG (AB) CEP CSPC migra-
tion can be
enhanced in vitro, a
new target or
regeneration
Benz et al.
(2013)
Human MACS (W5C5þ) Y CD49eþ, CD73þ,
CD90þ, CD105þ,
CD140bþ, CD166þ,
CD34, CD45,
CD271
C but limited O
and A
N In vitro 3D HSA-HA.
TGFb3
W5C5 enriched
and depleted,
articular
CSPCS
Sox9, Col2
(rtPCR) GAG
(DMMB)
CSPC chondrogen-
esis even after pro-
longed expansion,
W5C5 and W8B2
were not exclusively
required for
chondrogenicity
Brisby et al.
(2013)
Human IVD digest Y CD105þ, CD90þ,
Stro-lþ, Notch- 1þ,
Jagged-1
C N In vitro Pellet, TGFbl,
disk cell/BMSC
conditioned
media
þ/
conditioned
GAG (AB) CSPCs formed bet-
ter ECM in vitro
without BMSC
media
Wang et al.
(2014)
Human Agarose suspension Y CD90þ, CD105þ,
CD73þ, CD34,
CD45
O, A, C Y In vivo
(rabbit)
3D alginate
injected into
rabbit IVD
degeneration
model
BMSCs, CEP/
NP/AF CSPCs
GAG (AB)
MRI,
radiographs
Cartilage regenera-
tion after 6months
(CEP>MSC>N
P>AF)
Shi et al. (2015) Rat IVD digest Y CD29þ, CD44þ,
CD90þ, CD34,
CD45, CD19,
CDllb
O, A. C Y In vitro 2D high density BMSCs GAG (AB)
Sox9, Col2, Agg
(rtPCR)
CSPCs showed
greater chondro-
genesis than
controls
Xue et al.
(2015)
Porcine Fibronectin
adhesion
Y CD29þ, CD44þ,
CD90þ, CD34,
CD35
O, A, C Y In vitro 2D and pellet.
TGFbl and
FGF2
BMSCs, auricu-
lar/articular
CSPCs
Col 2, Agg,
COMP [rtPCR)
GAG (AB)
Col2 (IHC)
ESPCs showed
greater chondro-
genesis than
BMSCs
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that CSPCs were isolated from both the notochord derived nucleus
pulposus and the sclerotome-derived annulus ﬁbrosis and cartilage-
end plate (Risbud, 2011).
Interestingly, many of the MSC markers studied e.g., CD73 and
CD49e, have also found to be positive in mature chondrocytes
(Alsalameh, 2004; de la Fuente, 2004; Dowthwaite, 2004; Diaz-
Romero, 2008; and Williams, 2010) indicating lack of speciﬁcity.
Gogan et al. have also reported that the distribution of stem cell
markers (Notch-1, Stro-1, and VCAM-1) was not consistent with
stem cell distribution, concluding that these surface markers may not
be useful for identifying CSPCs (Grogan, 2009). If CSPCs prove to be
useful for future cartilage tissue engineering strategies, more efﬁcient
and speciﬁc isolation techniques will be required to isolate and purify
these cells for clinical use.
The progenitor vs stem cell status of CSPCs has been the topic
of much debate in the literature. Like chondrocytes, CSPCs have a
highly chondrogenic proﬁle, but trilineage potential and MSC
marker expression suggest a higher lineage than cartilage commit-
ted progenitors (Kobayashi, 2011). Although the limited self-
renewal of CSPCs, with senescence after 50PD (Khan, 2009) or
60PD (Koelling, 2009), has been previously used to deﬁne them as
progenitors rather than true stem cells, there is increasing evidence
that many adult stem cell sources also have a limited proliferative
history (Foudi, 2009 and Wilson, 2008). Of the 69 reports on CSPC
isolation, 24 met the ISCT criteria for an MSC (Dominici, 2006)
with no relationship with the type of isolation technique used,
which included migration assay, ﬁbronectin adhesion, and ﬂow or
magnetic cell sorting. Of those studies that did not meet ISCT crite-
ria, the majority were due to a simultaneous lack of trilineage and
immunophenotype assessment rather than actively failing to meet
stem cell criteria. This may be because the ﬁrst progenitor studies
predate Dominici criteria in 2006, thereby contributing to confu-
sion in nomenclature. Despite the evidence that these cells may rep-
resent a putative cartilage stem/progenitor cell maintaining
cartilage homeostasis in vivo, a few studies have identiﬁed and char-
acterized single cell-derived clonal subpopulations (Barbero, 2003;
Williams, 2010; and Yu, 2014) which means that phenotypic
“stemness” may be the result of a heterogeneous pool of cells
(Janebodin, 2011).
Evidence largely supports subtype-speciﬁc extracellular carti-
lage matrix secretion by CSPCs depending on their cartilage origin
using both in vitro and in vivo chondrogenesis models (McCarthy,
2012; Yoon, 2013; Williams, 2010; Anderson, 2017; Kobayashi,
2011; Takebe, 2012; and Kagimoto, 2016), although there are also
studies suggesting that ﬁbrocartilage rather than functional carti-
lage is formed (Derks, 2013; Dowthwaite, 2004; and Koelling,
2009). One study found that CSPCs of auricular elastic cartilage
origin are able to regenerate the hyaline cartilage suggesting their
potential for reprogramming these cells (Mizuno, 2014).
Nasoseptal CSPCs were shown to differentiate into neuronal line-
ages which may be attributed to their neuroectodermal origin
(Shaﬁee, 2011). A better understanding of the hierarchy of mesen-
chymal cell lineage may allow more focused rather than generic
characterization of CSPCs and allow them to have other applica-
tions beyond cartilage tissue engineering.
We do not yet know whether CSPCs maintain themselves within
their niche in native cartilage to promote repair through extracellularTA
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signaling factors or differentiate to maintain the cartilage tissue itself.
However, the ability of CSPCs to regenerate cartilage in vitro even after
prolonged expansion (Martin, 2005; Bernstein, 2013; Benz, 2013; and
Ozbey, 2014) suggests that tissue homeostasis involves an element of the
latter, because any mature chondrocytes within the CSPC enriched pop-
ulation would have been expected to dedifferentiate.
CSPCs unlike other stem cell sources [e.g., adipose derived stem
cells (ADSC), BMSC] are capable of spontaneous chondrogenic differ-
entiation in vitro (Keoelling, 2009 and Hattori, 2007), even in the
absence of growth factors, which makes them a more practical cell
source for cartilage tissue engineering (Baptista, 2013 and do Amaral,
2012). Both in vitro and in vivo studies indicate that BMSCs produce
cartilage that is hypertrophic rather than functional due to their line-
age preference for osteogenesis (McCarthy, 2012; Shen, 2014; and
Ding and Huang, 2015), whereas ADSCs fail to reproduce mature
extracellular matrix (Baptista, 2013 and Su, 2015). Although chondro-
cytes are shown to have comparable (Elsaesser, 2016; Togo, 2006;
Kobayashi, 2011; and Williams, 2010) or even superior (Seol, 2017;
TABLE IV. Positive cell surface markers for cartilage derived stem/progenitor cells (CSPCs). Number of studies reporting positive surface markers for different CSPC cartilage
sources.
Cell surface marker Articular Meniscal Auricular Nasoseptal Tracheal IVD Total
CDS 2 2
CD29 8 1 1 1 1 3 15
CD44 12 2 4 2 4 24
CD49a 1 1
CD49d 1 1
CD49e 4 2 2 8
CD49f 1 1
CD51 1 1
CD54 3 3
CD56 1 1
CD63 1 1
CD71 1 1
CD73 9 1 2 9 19
CD88 1 1
CD90 19 3 3 3 1 11 37
CD105 15 2 1 4 1 9 32
CD106 4 1 3 1 9
CD133 1 1 2 4
CD140b 1 1 2
CD146 2 2
CD166 13 1 2 6 24
CD184 1 1
CD271 1 1
Stro-1 7 2 3 12
Notch-1 9 1 10
Notch-2 1 1
Delta-1 2 2
Jagged-1 2 1 3
ABCG2 5 1 9
HLA-ABC 1 2 3
MSCA-1 1 1
p75NTR 1 1
SSEA-4 1 1
Nestin 1 1
Neuron-speciﬁc enolase 1 1
Tie2 1 1
GD2 1 1
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Marcus, 2014; and Zhou, 2016) cartilage regenerative capabilities,
unlike CSPCs (Martin, 2005; Bernstein, 2013; Benz, 2013; and Ozbey,
2016), they are not able to maintain their phenotype when expanded
in culture (McCarthy, 2012 and Williams, 2010). The presence of
meniscal and articular CSPCs has even been demonstrated in diseased
states and shown to regenerate cartilage in vitro (Alsalameh, 2004;
Bernstein, 2013; and Muhammad, 2014), but their susceptibility to
various inﬂammatory mediators i.e., NF-j B and ILb1 in late stages of
osteoarthritis may hamper their utility in vivo (Tong, 2015 and
Muhammad, 2014).
Limitations and future work
This systematic review has several limitations. Heterogeneity of
studies resulted from a lack of standardized CSPC isolation protocols,
chondrogenic culture methods (i.e., pellet, micromass or 3D scaffold),
experimental animals, and cartilage defects. None of the studies had
performed sample size calculations. Future studies should not only
characterize cartilage derived cells according to ISCT criteria to deter-
mine the progenitor vs stem cell status, but also investigate targeted
cell surface markers based on the developmental origin of cartilage
type rather than previously established MSC markers alone, to
improve our understanding of the overall CSPC immunophenotype.
Side-by-side studies directly comparing the chondrogenicity of CSPCs
with differentiated chondrocytes and other tissue derived MSCs are
required in order to deﬁnitively determine the utility of CSPCs for car-
tilage tissue engineering.
CONCLUSIONS
CSPCs have been shown to have excellent cartilage regenerative
ability using both in vitro and in vivo studies, with outcomes that are
TABLE V. Negative cell surface markers for cartilage derived stem/progenitor cells (CSPCs). Number of studies reporting negative surface markers for different CSPC cartilage
sources.
Cell surface marker Articular Meniscal Auricular Nasoseptal Tracheal IVD Totals
CD11b 1 1
CD14 3 3
CD17 1 1
CD19 4 A
CD24 1 1
CD31 1 1
CD34 8 3 2 2 8 23
CD35 1 1 1 3
CD45 10 2 2 1 7 22
CD117 1 1
CD133 2 1 2 5
CD138 1 1
CD140a 1 1
CD146 1 I 2
CD271 1 1 1 3
HLA-DR 2 2 4
MHC-11 1 1
TABLE VI. Summary of included studies on cartilage derived stem/progenitor cells (CSPCs). Stem cell classiﬁcation based on cartilage cells meeting all three minimal
International Society for Cellular Therapy criteria (Dominici,2006). 1. MSC must be plastic-adherent when maintained under standard culture conditions. 2. MSC must express
recognized stem cell surface markers (CD105, CD73, and CD90) and lack expression of unrelated markers (e.g., CD45, CD34, CD14, CD11b, CD79alpha or CD19, and HLA-
DR). 3. MSC must differentiate into osteoblasts, adipocytes, and chondroblasts in vitro. Those that did not meet all three criteria were classiﬁed as progenitors.
Study type
Classification of
cartilage cells
Number of studies
Articular Meniscal Nasoseptal Auricular IVD Tracheal Costochondral Total
In vitro Stem cells 9 1 2 1 5 … … 18
Progenitor cells 20 1 3 3 4 1 … 32
In vitro and in vivo Stem cells 1 2 … … 1 … … 4
Progenitor cells 2 … … … … … … 2
In vivo Stem cells … … … … 1 1 … 2
Progenitor cells 3 1 … 6 … … 1 11
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TABLE VII. In vivo applications of cartilage derived stem/progenitor cells (CSPCs) for cartilage repair. TGFb3, transforming growth factor b3; TGFb2, transforming growth factor b2; FGF2, ﬁbroblast growth factor
2; EGF, epidermal growth factor; IHC, immunohistochemistry; Histo, histology; ICRS, International Cartilage Repair Society; rtPCR, reverse transcriptase polymerase chain reaction; SEM, scanning electron
microscopy; SCID, severe combined immunodeﬁciency; NF-kB, nuclear factor kappa B; TGFb1, transforming growth factor b1; OA, osteoarthritis; HIF-2a, hypoxia inducible factor 2a; IGF1, insulin growth factor
1; BMSC, bone marrow derived mesenchymal stem cell; ECM, extracellular cartilage matrix; BMP2, bone morphogenetic protein 2; HUVEC, human umbilical vein endothelial cell; IVD, intervertebral disk; CEP,
cartilage endplate; NP, nucleus pulposus; AF, annulus ﬁbrosus; MRI, magnetic resonance imaging; and lCT, X-ray microtomography.
Clinical disease
model Study CSPC source
Species (no. per
treatment)
Study type (fol-
low-up period) Intervention Control group Outcome
Osteoarthritis Williams et al.
(2010)
Human articular
cartilage
Goat (6) Animal model
articular defect
(20 weeks)
Pellet and TGFb3 ﬁrst, then
loaded on 3D collagen with
TGFb2 El FGF2 (6mm defect)
Chondrocytes Cartilage formation conﬁrmed on tissue
samples (IHC, Histo), comparable ICRS
scores
Dowthwaite
et al. (2004)
Bovine articular
cartilage
Chick embryo
(ns)
Animal model
cartilage regen-
eration
(10 days)
Injection into the proximal
limb of developing chick
embryo
Tissue speciﬁc matrix synthesis in vivo,
resulting in articular ﬁbrocartilage
Singh et al.
(2013)
Rabbit articular
cartilage
Rabbit (24) Animal model
articular defect
(IS days)
Pellet ﬁrst, subchondral drilling,
then CSPCs in 3D collagen
(3mm defect)
Subchondral
drilling alone
CSPC group superior to control, as con-
ﬁrmed by radiology, arthroscopy, and
tissue samples (rtPCR, Histo, ICR5
score, and SEM)
Marcus et al.
(2014)
Bovine articular
cartilage
SCID mouse
(ns)
Animal model
(2 weeks)
Injection on the back of mouse Chondrocytes CSPCs did not produce any functional
matrix unlike chondrocytes (rtPCR,
1HC, and Histo)
Frisbie et al.
(2015)
Equine articular
cartilage
Horse (12) Animal model
articular defect
(6 and
12months)
3D ﬁbrin, TGFbl and FGF2
injected into horse articular
defect (16mm)
Fibrin only Autologous CSPCs superior to ﬁbrin
only and allogenic CSPC groups on
radiographs, arthroscopy, and tissue
samples (IHC and Histo)
Tong et al.
(2015)
Rat articular
carti1age
Rat (7–10) Animal model
OA (0, 2, 8, 14,
30, 60 or
90 days)
NF-xB inhibitor (BAYL1-7082)
injection twice a week
Dimethyl
sulfoxide
Inhibition of the NF-kB pathway acti-
vated CSPCs and slowed progression
OA
Shen et al.
(2013)
Rabbit meniscal
cartilage
Rabbit (3, 3,
and 12,
respectively)
Animal models
of meniscal
injury (4, 8, and
12)
Pellet, TGFbl, injection into
rabbits postmeniscectomy
Phosphate-
buffered saline
C5PC group showed more neo-tissue
formation than control at 4 and
8weeks, but not at 12 (IHC, Histo, and
biomechanical) and less OA
radiologically
Shen et al.
(2014)
Human meniscal
cartilage
Rat (3 and 3,
respectively)
Animal model
meniscal defect
(4 El 12weeks)
Injected into meniscal defect
rats
Phosphate-
buffered saline
CSPC group showed greater meniscal
regeneration than PBS at week 4, but
comparable at week 12 (IHC, TEM, and
Histo), with delay in OA via HIF 2a
inhibition
Mizuno et al.
(2014)
Canine auricular
cartilage
Dog (4) Animal model
articular defect
(60 days)
2D monolayer, IGF1 and FGF2,
cell clusters injected into canine
articular defect (4mm)
With and with-
out ﬁbrin glue
Formation of cartilage similar to hya-
line and biomechanically stiffer than
auricular cartilage (IHC and Histo)
Ding and
Huang (2015)
Rabbit meniscal
cartilage
Nude rat (4) Animal model
(3 weeks)
Implantation on the back of
mouse, CSPCs in matrigel
BMSC Matrigel-CSPCs expressed more colla-
gen 2 and less osteocalcin than controls
Facial
Reconstruction
Togo et al.
(2006)
Rabbit auricular
perichondrium
Nude mouse
(6)
Animal model
(4 weeks)
Pellet then seeded on 3D colla-
gen and injected dorsally in
nude mice
BMSCs and
chondrocytes
CSPCs formed more ECM than
BMSCs, but same as chondrocytes
(PCR, IHC, and Histo)
Kobayashi et al.
(2011) (i)
Human auricular
perichondrium
SCID mouse
(ns)
Animal model
(6 and
10months)
2D layered, FGF2 and IGF1,
injected SCID mice
Chondrocytes CSPCs formed elastic cartilage (chon-
drium and perichondrium) (IHC and
Histo)
Sterodimas and
de Faria (2013)
Rabbit auricular
cartilage
Rabbit (6) Animal model
(8 weeks)
Pellet, TGFb3 and BMP2,
seeded on 3D alginate/silk,
implanted dorsally in immuno-
competent rabbit
CSPCs from
chondrium and
perichondrium
Formation of carti1age with auricular
morphology (Histo)
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comparable to chondrocytes and superior to MSCs from unrelated tis-
sue sources. The current review concludes that CSPCs represent a
promising cell source for cartilage tissue engineering, but further work
is required to establish a consensus on nomenclature, speciﬁc cell sur-
face markers, and isolation protocols.
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